Jowhra Alshamrani

Ms. Jowhra Alshamrani

Taif University, Ta'if, Saudi Arabia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2022 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
BABandar Ali Alghamdi
Bandar Ali Alghamdi
IAIntisar Aljohani
Intisar Aljohani
BABandar Ghazi Alotaibi
Bandar Ghazi Alotaibi
MAMuhammad Ahmed
Muhammad Ahmed
KAKholod Abduallah Almazmomi
Kholod Abduallah Almazmomi
JAJowhra Alshamrani
Jowhra Alshamrani
Epigenetics is defined as the study of inheritable changes in the gene expressions and phenotypes that occurs without altering the normal DNA sequence. These changes are mainly due to an alteration in chromatin or its packaging, which changes the DNA accessibility. DNA methylation, histone modification, and noncoding or microRNAs can best explain the mechanism of epigenetics. There are various DNA methylated enzymes, histone-modifying enzymes, and microRNAs involved in the cause of various CVDs (cardiovascular diseases) such as cardiac hypertrophy, heart failure, and hypertension. Moreover, various CVD risk factors such as diabetes mellitus, hypoxia, aging, dyslipidemia, and their epigenetics are also discussed together with CVDs such as CHD (coronary heart disease) and PAH (pulmonary arterial hypertension). Furthermore, different techniques involved in epigenetic chromatin mapping are explained. Among these techniques, the ChIP-on-chip guide is explained with regard to its role in cardiac hypertrophy, a final form of heart failure. This review focuses on different epigenetic factors that are involved in causing cardiovascular diseases.